![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » MYLAN GETS NEW EMSAM PATENT
MYLAN GETS NEW EMSAM PATENT
July 27, 2006
Drug maker Mylan Laboratories Inc. announced that its Mylan Technologies unit received an additional patent covering the Emsam antidepressant patch. The company said the patent, issued on July 4, covers the delivery of Emsam's active ingredient selegiline through the skin. Yahoo Finance (http://biz.yahoo.com/ap/060726/mylan_patent.html?.v=2)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct